about
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancerActive angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy.Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer.PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effectsPyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancerc-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer.PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.Recent advances and clinical insights into the use of proteomics in the study of atherosclerosis.Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.A comprehensive study of calcific aortic stenosis: from rabbit to human samples.Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancerUNR/CSDE1 Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.Up-regulation of c-Cbl suggests its potential role as oncogene in primary colorectal cancerPotential involvement of protein phosphatase 2A in temsirolimus-mediated resensitization to cetuximab in colon cancer cellsDeregulation of miR-200b, miR-200c and miR-429 indicates its potential relevant role in patients with colorectal cancer liver metastasisHyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation
P50
Q27853142-A52D16E6-58E3-46B5-9160-6B854DD7F508Q33682981-7CFDB9DD-6BE5-4FE4-B7C0-171D515CE4D7Q34051988-9383A398-DB5E-48FB-9F5A-4AD843492219Q35552005-F6539E2B-9C85-4305-A736-143248ED55BAQ36088709-0A122711-34A3-49EA-84CF-803CEFEA2DB3Q37649660-2AD84C59-E801-4811-99AF-ACF03B2BBCB8Q38733953-66482652-28DD-4519-BBBF-97068D56661DQ38941215-D37C772B-1BF4-425E-84BA-1C815ED7E3A5Q39032127-8FC74B9E-7036-4847-81E4-1A75042F3A80Q39423557-5FD4E567-C1BD-405F-ACBD-256EC422997AQ41093440-6D23DA4E-5E7D-4656-ABF7-C67F22B06E82Q52647946-24B20001-E8B9-46D2-BFDE-5536CE014A27Q53026600-4A8628E5-27BD-4923-9C5A-619586A2D3F8Q55441114-DA242C2B-2BCB-45E6-919A-38D72DB8EF33Q64116258-1E9CFFDB-A2EA-4FEA-9603-DEF643B38546Q64915221-FC72381E-CCFF-4148-A6D9-CC8E2F767A72Q87288391-4C6D2D2C-FA14-48E4-910D-E22F16725204Q87875664-D5336099-2F76-4398-BA94-ACD1E59E251AQ88054859-50629BDE-D661-4006-AD45-8BC5DABF665CQ88222244-8E21742E-2168-481D-B706-10E3FAF51B2B
P50
description
researcher ORCID ID = 0000-0003-0576-0618
@en
wetenschapper
@nl
name
Raúl Rincón
@ast
Raúl Rincón
@en
Raúl Rincón
@nl
type
label
Raúl Rincón
@ast
Raúl Rincón
@en
Raúl Rincón
@nl
prefLabel
Raúl Rincón
@ast
Raúl Rincón
@en
Raúl Rincón
@nl
P21
P31
P496
0000-0003-0576-0618